Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2013-07-29
Original market date: See footnote 1
2006-02-22
Product name:
PHOSLO TABLETS
DIN:
02229437
Product Monograph/Veterinary Labelling:
Date:
2007-02-20
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
FRESENIUS MEDICAL CARE NORTH AMERICA
920 Winter Street
Waltham
Massachusetts
United States
02451-1457
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
40:18.19
Anatomical Therapeutic Chemical (ATC): See footnote 4
V03AE DRUGS FOR TREATMENT OF HYPERKALEMIA AND HYPERPHOSPHATEMIA
Active ingredient group (AIG) number:See footnote5
0123586005
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| CALCIUM ACETATE | 667 MG |